Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Safety and Efficacy of Palliative Radiotherapy (25 Gy × 5 Fractions) for Symptomatic Pelvic Tumors

TOMOMI AOSHIKA, TAKANORI ABE, MISAKI IINO, SATOSHI SAITO, YASUHIRO RYUNO, TOMOHIRO OHTA, MITSUNOBU IGARI, RYUTA HIRAI, YU KUMAZAKI, SHIN-EI NODA and SHINGO KATO
Anticancer Research December 2022, 42 (12) 6099-6103; DOI: https://doi.org/10.21873/anticanres.16122
TOMOMI AOSHIKA
Department of Radiation Oncology, International Medical Center, Saitama Medical University, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKANORI ABE
Department of Radiation Oncology, International Medical Center, Saitama Medical University, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mrtaka100{at}yahoo.co.jp
MISAKI IINO
Department of Radiation Oncology, International Medical Center, Saitama Medical University, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SATOSHI SAITO
Department of Radiation Oncology, International Medical Center, Saitama Medical University, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUHIRO RYUNO
Department of Radiation Oncology, International Medical Center, Saitama Medical University, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMOHIRO OHTA
Department of Radiation Oncology, International Medical Center, Saitama Medical University, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MITSUNOBU IGARI
Department of Radiation Oncology, International Medical Center, Saitama Medical University, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RYUTA HIRAI
Department of Radiation Oncology, International Medical Center, Saitama Medical University, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YU KUMAZAKI
Department of Radiation Oncology, International Medical Center, Saitama Medical University, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHIN-EI NODA
Department of Radiation Oncology, International Medical Center, Saitama Medical University, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHINGO KATO
Department of Radiation Oncology, International Medical Center, Saitama Medical University, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 42 no. 12 6099-6103
DOI 
https://doi.org/10.21873/anticanres.16122
PubMed 
36456125

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received October 27, 2022
  • Revision received November 4, 2022
  • Accepted November 8, 2022
  • Published online December 1, 2022.

Copyright & Usage 
Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. TOMOMI AOSHIKA*,
  2. TAKANORI ABE⇑*,
  3. MISAKI IINO,
  4. SATOSHI SAITO,
  5. YASUHIRO RYUNO,
  6. TOMOHIRO OHTA,
  7. MITSUNOBU IGARI,
  8. RYUTA HIRAI,
  9. YU KUMAZAKI,
  10. SHIN-EI NODA and
  11. SHINGO KATO
  1. Department of Radiation Oncology, International Medical Center, Saitama Medical University, Saitama, Japan
  1. Correspondence to: Takanori Abe, Department of Radiation Oncology, International Medical Center, Saitama Medical University, 1397-1, Yamane, Hidaka, Saitama 350-1298, Japan. Tel: +81 429844136, Fax: +81 429844136, e-mail: mrtaka100{at}yahoo.co.jp
  1. ↵* These Authors contributed equally to this study.

View Full Text

Statistics from Altmetric.com

Cited By...

  • 6 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 42 (12)
Anticancer Research
Vol. 42, Issue 12
December 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Safety and Efficacy of Palliative Radiotherapy (25 Gy × 5 Fractions) for Symptomatic Pelvic Tumors
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Safety and Efficacy of Palliative Radiotherapy (25 Gy × 5 Fractions) for Symptomatic Pelvic Tumors
TOMOMI AOSHIKA, TAKANORI ABE, MISAKI IINO, SATOSHI SAITO, YASUHIRO RYUNO, TOMOHIRO OHTA, MITSUNOBU IGARI, RYUTA HIRAI, YU KUMAZAKI, SHIN-EI NODA, SHINGO KATO
Anticancer Research Dec 2022, 42 (12) 6099-6103; DOI: 10.21873/anticanres.16122

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Safety and Efficacy of Palliative Radiotherapy (25 Gy × 5 Fractions) for Symptomatic Pelvic Tumors
TOMOMI AOSHIKA, TAKANORI ABE, MISAKI IINO, SATOSHI SAITO, YASUHIRO RYUNO, TOMOHIRO OHTA, MITSUNOBU IGARI, RYUTA HIRAI, YU KUMAZAKI, SHIN-EI NODA, SHINGO KATO
Anticancer Research Dec 2022, 42 (12) 6099-6103; DOI: 10.21873/anticanres.16122
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Palliative Radiation Treatment in Patients Managed With Advanced/Interventional Pain Therapy such as Pump-delivered Continuous Opioids
  • Google Scholar

More in this TOC Section

  • The Posterior First Approach in Robot-assisted Radical Prostatectomy for Prostate Cancer Reduces Positive Surgical Margins on the Bladder Neck Side
  • Gamma Knife Radiotherapy of Brain Metastasis Resection Cavities: Outcome Analysis of a Single-center Cohort
  • Efficacy and Safety of Chemoimmunotherapy in Patients With Advanced Non-small Cell Lung Cancer With Pre-existing Interstitial Pneumonia and Low PD-L1 Expression
Show more Clinical Studies

Similar Articles

Keywords

  • palliative radiotherapy
  • 25 Gy/5 fr
  • pelvic tumors
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire